<?xml version="1.0" encoding="UTF-8" standalone="no"?><!--IFOTB V2.1 (26-06-2026)--><xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:in-capmkt="http://www.sebi.gov.in/xbrl/2026-01-31/in-capmkt" xmlns:in-capmkt-ent="http://www.sebi.gov.in/xbrl/IntegratedFinance_OtherThanBank/2026-01-31/in-capmkt/in-capmkt-ent" xmlns:in-capmkt-roles="http://www.sebi.gov.in/xbrl/IntegratedFinance_OtherThanBank/2026-01-31/in-capmkt-roles" xmlns:in-capmkt-type="http://www.sebi.gov.in/xbrl/2026-01-31/in-capmkt-types" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink"><link:schemaRef xlink:href="in-capmkt-ent-2026-01-31.xsd" xlink:type="simple"/><xbrli:context id="OneD"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="OneI"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="PY_I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="OneExpenses1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneExpenses2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentLiabilities1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentLiabilitiesAxis"><in-capmkt:OtherCurrentLiabilitiesDomain>OtherCurrentLiabilitiesDomain1</in-capmkt:OtherCurrentLiabilitiesDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherNoncurrentAssets1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/ScripCode">000000</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherNoncurrentAssetsAxis"><in-capmkt:OtherNoncurrentAssetsDomain>OtherNoncurrentAssetsDomain1</in-capmkt:OtherNoncurrentAssetsDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:unit id="INR"><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unit><xbrli:unit id="INRPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><in-capmkt:ScripCode contextRef="OneD">000000</in-capmkt:ScripCode><in-capmkt:Symbol contextRef="OneD">MEDIORG</in-capmkt:Symbol><in-capmkt:MSEISymbol contextRef="OneD">NOTLISTED</in-capmkt:MSEISymbol><in-capmkt:ISIN contextRef="OneD">INE0PE401018</in-capmkt:ISIN><in-capmkt:NameOfTheCompany contextRef="OneD">Medicamen Organics Limited</in-capmkt:NameOfTheCompany><in-capmkt:TypeOfCompany contextRef="OneD">SME</in-capmkt:TypeOfCompany><in-capmkt:ClassOfSecurity contextRef="OneD">Equity</in-capmkt:ClassOfSecurity><in-capmkt:DateOfStartOfFinancialYear contextRef="OneD">2026-04-01</in-capmkt:DateOfStartOfFinancialYear><in-capmkt:DateOfEndOfFinancialYear contextRef="OneD">2027-03-31</in-capmkt:DateOfEndOfFinancialYear><in-capmkt:DateOfBoardMeetingWhenFinancialResultsWereApproved contextRef="OneD">2026-11-14</in-capmkt:DateOfBoardMeetingWhenFinancialResultsWereApproved><in-capmkt:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange contextRef="OneD">2026-11-06</in-capmkt:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange><in-capmkt:DescriptionOfPresentationCurrency contextRef="OneD">INR</in-capmkt:DescriptionOfPresentationCurrency><in-capmkt:LevelOfRounding contextRef="OneD">Lakhs</in-capmkt:LevelOfRounding><in-capmkt:TypeOfReportingPeriod contextRef="OneD">Half Yearly</in-capmkt:TypeOfReportingPeriod><in-capmkt:ReportingQuarter contextRef="OneD">Half yearly</in-capmkt:ReportingQuarter><in-capmkt:IsCompanyReportingMultisegmentOrSingleSegment contextRef="OneD">Single segment</in-capmkt:IsCompanyReportingMultisegmentOrSingleSegment><in-capmkt:DescriptionOfSingleSegment contextRef="OneD">Pharmacuticals</in-capmkt:DescriptionOfSingleSegment><in-capmkt:DateOfStartOfBoardMeeting contextRef="OneD">2026-11-14</in-capmkt:DateOfStartOfBoardMeeting><in-capmkt:StartTimeOfBoardMeeting contextRef="OneD">18:30:00</in-capmkt:StartTimeOfBoardMeeting><in-capmkt:DateOfEndOfBoardMeeting contextRef="OneD">2026-11-14</in-capmkt:DateOfEndOfBoardMeeting><in-capmkt:EndTimeOfBoardMeeting contextRef="OneD">21:30:00</in-capmkt:EndTimeOfBoardMeeting><in-capmkt:WhetherCashFlowStatementIsApplicableOnCompany contextRef="OneD">true</in-capmkt:WhetherCashFlowStatementIsApplicableOnCompany><in-capmkt:TypeOfCashFlowStatement contextRef="OneD">Cash Flow Indirect</in-capmkt:TypeOfCashFlowStatement><in-capmkt:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification contextRef="OneD">Not applicable</in-capmkt:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification><in-capmkt:DateOfStartOfReportingPeriod contextRef="OneD">2026-04-01</in-capmkt:DateOfStartOfReportingPeriod><in-capmkt:DateOfEndOfReportingPeriod contextRef="OneD">2026-09-30</in-capmkt:DateOfEndOfReportingPeriod><in-capmkt:WhetherResultsAreAuditedOrUnaudited contextRef="OneD">Unaudited</in-capmkt:WhetherResultsAreAuditedOrUnaudited><in-capmkt:NatureOfReportStandaloneConsolidated contextRef="OneD">Consolidated</in-capmkt:NatureOfReportStandaloneConsolidated><in-capmkt:RevenueFromOperations contextRef="OneD" decimals="-3" unitRef="INR">69905000</in-capmkt:RevenueFromOperations><in-capmkt:OtherIncome contextRef="OneD" decimals="-3" unitRef="INR">1254000</in-capmkt:OtherIncome><in-capmkt:Income contextRef="OneD" decimals="-3" unitRef="INR">71159000</in-capmkt:Income><in-capmkt:CostOfMaterialsConsumed contextRef="OneD" decimals="-3" unitRef="INR">46257000</in-capmkt:CostOfMaterialsConsumed><in-capmkt:PurchasesOfStockInTrade contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PurchasesOfStockInTrade><in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade contextRef="OneD" decimals="-3" unitRef="INR">2467000</in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade><in-capmkt:EmployeeBenefitExpense contextRef="OneD" decimals="-3" unitRef="INR">22134000</in-capmkt:EmployeeBenefitExpense><in-capmkt:FinanceCosts contextRef="OneD" decimals="-3" unitRef="INR">4431000</in-capmkt:FinanceCosts><in-capmkt:DepreciationAndAmortisationExpense contextRef="OneD" decimals="-4" unitRef="INR">4950000</in-capmkt:DepreciationAndAmortisationExpense><in-capmkt:OtherExpenses contextRef="OneD" decimals="-3" unitRef="INR">33524000</in-capmkt:OtherExpenses><in-capmkt:Expenses contextRef="OneD" decimals="-3" unitRef="INR">113763000</in-capmkt:Expenses><in-capmkt:ProfitBeforeExceptionalAndExtraordinaryItemsAndTax contextRef="OneD" decimals="-3" unitRef="INR">-42604000</in-capmkt:ProfitBeforeExceptionalAndExtraordinaryItemsAndTax><in-capmkt:ExceptionalItems contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ExceptionalItems><in-capmkt:ProfitBeforeExtraordinaryItemsAndTax contextRef="OneD" decimals="-3" unitRef="INR">-42604000</in-capmkt:ProfitBeforeExtraordinaryItemsAndTax><in-capmkt:ExtraordinaryItems contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ExtraordinaryItems><in-capmkt:ProfitBeforeTax contextRef="OneD" decimals="-3" unitRef="INR">-42604000</in-capmkt:ProfitBeforeTax><in-capmkt:CurrentTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CurrentTax><in-capmkt:DeferredTax contextRef="OneD" decimals="-3" unitRef="INR">-1126000</in-capmkt:DeferredTax><in-capmkt:TaxExpense contextRef="OneD" decimals="-3" unitRef="INR">-1126000</in-capmkt:TaxExpense><in-capmkt:ProfitLossForThePeriodFromContinuingOperations contextRef="OneD" decimals="-3" unitRef="INR">-41478000</in-capmkt:ProfitLossForThePeriodFromContinuingOperations><in-capmkt:ProfitLossFromDiscontinuingOperationsBeforeTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuingOperationsBeforeTax><in-capmkt:TaxExpenseOfDiscontinuingOperations contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:TaxExpenseOfDiscontinuingOperations><in-capmkt:ProfitLossFromDiscontinuingOperationAfterTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuingOperationAfterTax><in-capmkt:ProfitLossForPeriodBeforeMinorityInterest contextRef="OneD" decimals="-3" unitRef="INR">-41478000</in-capmkt:ProfitLossForPeriodBeforeMinorityInterest><in-capmkt:ShareOfProfitLossOfAssociates contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ShareOfProfitLossOfAssociates><in-capmkt:ProfitLossOfMinorityInterest contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossOfMinorityInterest><in-capmkt:ProfitLossForThePeriod contextRef="OneD" decimals="-3" unitRef="INR">-41478000</in-capmkt:ProfitLossForThePeriod><in-capmkt:PaidUpValueOfEquityShareCapital contextRef="OneD" decimals="-3" unitRef="INR">148802000</in-capmkt:PaidUpValueOfEquityShareCapital><in-capmkt:FaceValueOfEquityShareCapital contextRef="OneD" decimals="INF" unitRef="INRPerShare">10</in-capmkt:FaceValueOfEquityShareCapital><in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">2.99</in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">2.99</in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock contextRef="OneD">Notes to Accounts &lt;br /&gt; 
1	The consolidated reviewed financial results are prepared in accordance with the Accounting Standards Prescribed urder Section 133 of the Companies Act,2013 read with Rule 7 of the Companies (Accounts) Rules, 2014 (as amended) and other recognised accounting practices and policies, as applicable. &lt;br /&gt; 
 &lt;br /&gt; 
2	The company has signed a Memorandum of understanding (MOU) (dated 15th July 2024) and share sale agreement (dated 08 October 2024) with the Depot Pharmacy Yego Ltd. (Rwanda, East Africa based company) having corporate office at Plot No B1 Kigali City Market, Nyarugenge Kigali-20093, Rwanda East Africa. The company has invested 51% stake in Depot Pharmacy Yego Ltd. The transaction to acquire the DPYL was 08-10-2024 but Actual transaction is completed on 16-01-2025 which is the acquisition date for the company. &lt;br /&gt; 
 &lt;br /&gt; 
The company has incorporated a subsidiary on 27th December 2024  in the name of Grande Etoile Pharmaceuticals Limited with 50.92% of share holidng in the same company. &lt;br /&gt; 
 &lt;br /&gt; 
3	The Statutory Auditors of the Company have reviewed of the above results as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. &lt;br /&gt; 
 &lt;br /&gt; 
4	There were no investor complaints known to the Company outstanding at the beginning and at the end of the half year ended on September 30, 2026. &lt;br /&gt; 
 &lt;br /&gt; 
5	The results of the Company are also available for investors at www.medicamenorganics.com and www.nseindia.com &lt;br /&gt; 
 &lt;br /&gt; 
6	 The above consolidated reviewed financial results for the Half year ended September 30, 2026 have been prepared by the Company were reviewed and recommended by the Audit Committee of the Board and thereafter were approved and taken on record by the Board of Directors in their respective meetings held on November 14, 2026 Above results has been reviewed by the statutory auditors of the company. &lt;br /&gt; 
 &lt;br /&gt; 
7	The company has received intimation from suppliers regarding their status under Micro, Small and Medium Enterprises Development Act 2006 and disclosures relating  to the amount unpaid as at year end, as required under the said Act, have been provided. The Company has provided the interest on outstanding from supplier under Micro, Small and Medium Enterprises as on 30-09-2026. &lt;br /&gt; 
 &lt;br /&gt; 
8	The Results for the half-year ended and year ended September 30th, 2026 are reviewed by the statutory auditor of the company in compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. &lt;br /&gt; 
 &lt;br /&gt; 
9	These financial results have been prepared in accordance with the recognition and measurement principles of Accounting Standards ("AS") prescribed section 133 of the Companies Act 2013 (the "Act") read with relevant rules issued thereunder and the other accounting principles generally accepted in India. &lt;br /&gt; 
 &lt;br /&gt; 
10	The Earning Per Share (EPS) has been computed in accordance with the Accounting Standard on Earnings Per Share (AS 20).  EPS for the half year ended September 30th, 2026, March 31st, 2026, and September 30th, 2025, are not annuualised. The weighted average number of equity shares outstanding during the period has been considered for calculating the basic and diluted earnings per share in accordance with the Accounting Standard 20. &lt;br /&gt; 
 &lt;br /&gt; 
11	The comparative results for the half-year ended and year ended September 30th, 2026 have been reviewed by the statutory auditors of the Company. &lt;br /&gt; 
 &lt;br /&gt; 
12	The figures for the half-year ended March 31st, 2026 are balancing figures between reviewed figures in respect of the full financial year ended March 31st, 2026 and the unreviewed half-year ended September 30th 2025. &lt;br /&gt; 
 &lt;br /&gt; 
13	The company has issued 31,00,000 equity shares of Rs. 10 each at a premium of Rs. 24 each by way of initial public offer ("IPO") and got listed on Emerge Platform of National Stock Exchange of India Limited on June 28th, 2024. &lt;br /&gt; 
 &lt;br /&gt; 
14	CONTINGENT LIABILITIES AND PENDING LITIGATIONS &lt;br /&gt; 
 &lt;br /&gt; 
14A	Contingent Liabilities &lt;br /&gt; 
 &lt;br /&gt; 
Particulars	Next date of Hearing	As at 30-09-2026	As at 31-03-2026 &lt;br /&gt; 
a. Case against the company filed by Prakash Parcel Services Ltd.	05-12-2026	2.34	2.34 &lt;br /&gt; 
b. Case against the company filed by Multani Pharmaceuticals	05-01-2027	7.18	7.18 &lt;br /&gt; 
c. Margin money (FDR) for Bank Guarantee on behalf of third party &lt;br /&gt; 
(Margin FDR  of Rs.56200/-)		5.62	6.42 &lt;br /&gt; 
 &lt;br /&gt; 
(In Lakhs) &lt;br /&gt; 
14B	 &lt;br /&gt; 
 &lt;br /&gt; 
Name of the statute	Nature of the dues	Amount (Rs. in lakhs)	Financial Year	Description	Forum where dispute is pending &lt;br /&gt; 
Income Tax Department	Income tax 	13.27	AY 2017-18	Assessment year 	Commissioner of income tax (Appeal) &lt;br /&gt; 
(b) Goods and Service Tax	GST (Uttrakhand)	64.19	FY 2023-24	Financial year 	Deputy Commissioner &lt;br /&gt; 
(c) Goods and Service Tax	GST (Uttrakhand)	138.28	FY 2022-23	Financial year 	Deputy Commissioner &lt;br /&gt; 
 &lt;br /&gt; 
14C	Detail of Pending Litigation &lt;br /&gt; 
 &lt;br /&gt; 
Name of the Party	Nature of the dues	Amount (Rs. in lakhs)	Next date of Hearing	Description	Forum where dispute is pending &lt;br /&gt; 
Europa Biocare P Ltd	Civil Case	7.23	05-12-2026	The company has filed recovery suit (civil case) against the defaulter party 	Rohini (Court) &lt;br /&gt; 
M/S Wafture Healthcare P Ltd	Civil Case	5.7	04-03-2027	The company has filed recovery suit (civil case) against the defaulter party 	Rohini (Court) &lt;br /&gt; 
Paseca Health Care	Civil Case	5.53	Earlier Hearing date 29-07-2026 response to be filed by the company	The company has filed recovery suit (civil case) against the defaulter party 	Rohini (Court) &lt;br /&gt; 
Ujjwal Overseas	Civil Case	17.17	Earlier Hearing date 29-07-2026 response to be filed by the company	The company has filed recovery suit (civil case) against the defaulter party 	Rohini (Court) &lt;br /&gt; 
Karnataka State Medical supplies Corporation Ltd	Civil Case	80.87	21-07-2026	The company has filed recovery suit (NI Act case) against the defaulter party 	Rohini (Court) &lt;br /&gt; 
 &lt;br /&gt; 
15	During the half year ended September 30, 2026, the Management Committee of the Board of Directors of the Company, at its meeting held on June 09, 2026, approved the allotment of 27,14,285 equity shares having a face value of Rs.10/- each at an issue price of Rs.35/- per equity share (including a securities premium of Rs.25/- per equity share), aggregating to Rs.9,49,99,975/-, on a preferential basis. The said allotment comprised 7,14,285 equity shares to Mr. Bal Kishan Gupta (Promoter), against conversion of an outstanding loan amounting to Rs.2,49,99,975/-, and 20,00,000 equity shares to Mr. Pradeep Kumar Jain (Non-Promoter), for cash consideration aggregating to Rs.7,00,00,000/-. &lt;br /&gt; 
 &lt;br /&gt; 
Further, at the same meeting, the Management Committee approved the allotment of 11,85,715 convertible warrants on a preferential basis, comprising 1,85,715 warrants to Mr. Bal Kishan Gupta (Promoter) and 10,00,000 warrants to Mr. Pradeep Kumar Jain (Non-Promoter). &lt;br /&gt; 
 &lt;br /&gt; 
16	Sundry creditors of the company include Rs.40.21 Lakhs received in March 2025, from a foreign customer, M/s Escorts Pharmaceuticals Rwanda Limited (EPRL). No supplies were executed against this advance during the financial year ended March 31, 2026. Due to the ongoing geopolitical tensions and conflict situation in the East African region, including disruptions arising from the Rwanda–DRC border instability and war-like conditions, the Company has been facing significant logistical and transportation challenges in executing export shipments to Rwanda. &lt;br /&gt; 
 &lt;br /&gt; 
Although advance/payment was received from Escort Pharmaceuticals, Rwanda, the export of goods could not be completed within the expected timeline due to uncertainty in cross-border movement, shipping constraints, safety concerns, and disruption in international trade routes. The matter is under continuous review, and the Company is coordinating with the customer and logistics partners for further course of action.” &lt;br /&gt; 
 &lt;br /&gt; 
17	For the purpose of consolidation of financial statements, Medicamen Organics Limited has considered the Books of Accounts of Grande Etoile Pharmaceuticals Limited and Loire Cosmetics Limited in accordance with the applicable accounting standards and regulatory requirements. The books of accounts of the foreign subsidiary (Depot Pharmacy Yego Ltd) has not been consolidated in the consolidated financial results of Medicamen Organics Limited due to non availability of books of accounts. &lt;br /&gt; 
 &lt;br /&gt; 
18	Accounting Standard 21"Consolidated Financial Statements" is applied in the preparation and presentation of consolidated financial statements for a group of enterprises under the control of a parent. &lt;br /&gt; 
 &lt;br /&gt; 
19	Medicamen Organics Limited has a subsidiary namely Grande Etoile Pharmaceuticals Limited. &lt;br /&gt; 
Further, Grande Etoile Pharmaceuticals Limited has incorporated a subsidiary company namely Loire Cosmetics Limited on 03 September 2025 with a shareholding of 50.75%. &lt;br /&gt; 
 &lt;br /&gt; 
Accordingly, Loire Cosmetics Limited has become a step-down subsidiary of Medicamen Organics Limited w.e.f. 03 September 2025. &lt;br /&gt; 
 &lt;br /&gt; 
20	Balances of some debtors and creditors are subject to their confirmations. &lt;br /&gt; 
 &lt;br /&gt; 
21	As per the assessment of the management, the recoverable amount of assets is higher than it carrying value and hence no impairment of assets needs to be recorded in the financial statements. &lt;br /&gt; 
 &lt;br /&gt; 
22	Previous year/period's figures have been regrouped/reclassified wherever necessary to correspond with the current period's classification for comparison. &lt;br /&gt; 
 &lt;br /&gt; 
23	As the Company's business activity falls within a single primary business segment i.e. the disclosure requirements as per AS 17 "Segment Reporting" are not applicable. &lt;br /&gt; 
</in-capmkt:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock><in-capmkt:DescriptionOfOtherExpenses contextRef="OneExpenses1D">Direct Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="OneExpenses1D" decimals="-3" unitRef="INR">18741000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="OneExpenses2D">Other Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="OneExpenses2D" decimals="-3" unitRef="INR">14783000</in-capmkt:OtherExpenses><in-capmkt:ShareCapital contextRef="OneI" decimals="-3" unitRef="INR">148802000</in-capmkt:ShareCapital><in-capmkt:ReservesAndSurplus contextRef="OneI" decimals="-3" unitRef="INR">192434000</in-capmkt:ReservesAndSurplus><in-capmkt:MoneyReceivedAgainstShareWarrants contextRef="OneI" decimals="-3" unitRef="INR">27875000</in-capmkt:MoneyReceivedAgainstShareWarrants><in-capmkt:ShareholdersFunds contextRef="OneI" decimals="-3" unitRef="INR">369111000</in-capmkt:ShareholdersFunds><in-capmkt:ShareApplicationMoneyPendingAllotment contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:ShareApplicationMoneyPendingAllotment><in-capmkt:DeferredGovernmentGrants contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:DeferredGovernmentGrants><in-capmkt:MinorityInterest contextRef="OneI" decimals="-3" unitRef="INR">-2032000</in-capmkt:MinorityInterest><in-capmkt:LongTermBorrowings contextRef="OneI" decimals="-3" unitRef="INR">9996000</in-capmkt:LongTermBorrowings><in-capmkt:DeferredTaxLiabilitiesNet contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:DeferredTaxLiabilitiesNet><in-capmkt:ForeignCurrencyMonetaryItemTranslationDifferenceLiabilityAccount contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:ForeignCurrencyMonetaryItemTranslationDifferenceLiabilityAccount><in-capmkt:LongTermProvisions contextRef="OneI" decimals="-3" unitRef="INR">2889000</in-capmkt:LongTermProvisions><in-capmkt:NoncurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">12885000</in-capmkt:NoncurrentLiabilities><in-capmkt:ShortTermBorrowings contextRef="OneI" decimals="-3" unitRef="INR">108558000</in-capmkt:ShortTermBorrowings><in-capmkt:TotalOutstandingDuesOfMicroEnterprisesAndSmallEnterprises contextRef="OneI" decimals="-3" unitRef="INR">13316000</in-capmkt:TotalOutstandingDuesOfMicroEnterprisesAndSmallEnterprises><in-capmkt:TotalOutstandingDuesOfCreditorsOtherThanMicroEnterprisesAndSmallEnterprises contextRef="OneI" decimals="-3" unitRef="INR">41878000</in-capmkt:TotalOutstandingDuesOfCreditorsOtherThanMicroEnterprisesAndSmallEnterprises><in-capmkt:TradePayables contextRef="OneI" decimals="-3" unitRef="INR">55194000</in-capmkt:TradePayables><in-capmkt:OtherCurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">24364000</in-capmkt:OtherCurrentLiabilities><in-capmkt:ShortTermProvisions contextRef="OneI" decimals="-3" unitRef="INR">556000</in-capmkt:ShortTermProvisions><in-capmkt:CurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">188672000</in-capmkt:CurrentLiabilities><in-capmkt:EquityAndLiabilities contextRef="OneI" decimals="-3" unitRef="INR">568636000</in-capmkt:EquityAndLiabilities><in-capmkt:PropertyPlantAndEquipment contextRef="OneI" decimals="-3" unitRef="INR">132822000</in-capmkt:PropertyPlantAndEquipment><in-capmkt:ProducingProperties contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:ProducingProperties><in-capmkt:IntangibleAssets contextRef="OneI" decimals="-5" unitRef="INR">5000000</in-capmkt:IntangibleAssets><in-capmkt:PreproducingProperties contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:PreproducingProperties><in-capmkt:PropertyPlantAndEquipmentCapitalWorkInProgress contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:PropertyPlantAndEquipmentCapitalWorkInProgress><in-capmkt:IntangibleAssetsUnderDevelopmentOrWorkInProgress contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:IntangibleAssetsUnderDevelopmentOrWorkInProgress><in-capmkt:PropertyPlantAndEquipmentAndIntangibleAssets contextRef="OneI" decimals="-3" unitRef="INR">137822000</in-capmkt:PropertyPlantAndEquipmentAndIntangibleAssets><in-capmkt:NoncurrentInvestments contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:NoncurrentInvestments><in-capmkt:DeferredTaxAssetsNet contextRef="OneI" decimals="-3" unitRef="INR">2117000</in-capmkt:DeferredTaxAssetsNet><in-capmkt:ForeignCurrencyMonetaryItemTranslationDifferenceAssetAccount contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:ForeignCurrencyMonetaryItemTranslationDifferenceAssetAccount><in-capmkt:LongTermLoansAndAdvances contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:LongTermLoansAndAdvances><in-capmkt:OtherNoncurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">11039000</in-capmkt:OtherNoncurrentAssets><in-capmkt:NoncurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">150978000</in-capmkt:NoncurrentAssets><in-capmkt:CurrentInvestments contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:CurrentInvestments><in-capmkt:Inventories contextRef="OneI" decimals="-3" unitRef="INR">102968000</in-capmkt:Inventories><in-capmkt:TradeReceivables contextRef="OneI" decimals="-3" unitRef="INR">160154000</in-capmkt:TradeReceivables><in-capmkt:CashAndCashEquivalents contextRef="OneI" decimals="-3" unitRef="INR">26145000</in-capmkt:CashAndCashEquivalents><in-capmkt:BankBalanceOtherThanCashAndCashEquivalents contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:BankBalanceOtherThanCashAndCashEquivalents><in-capmkt:ShortTermLoansAndAdvances contextRef="OneI" decimals="-3" unitRef="INR">128391000</in-capmkt:ShortTermLoansAndAdvances><in-capmkt:CurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">417658000</in-capmkt:CurrentAssets><in-capmkt:Assets contextRef="OneI" decimals="-3" unitRef="INR">568636000</in-capmkt:Assets><in-capmkt:DescriptionOfOtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities1">Other Current Liabilities</in-capmkt:DescriptionOfOtherCurrentLiabilities><in-capmkt:OtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities1" decimals="-3" unitRef="INR">24364000</in-capmkt:OtherCurrentLiabilities><in-capmkt:DescriptionOfOtherNoncurrentAssets contextRef="I_OtherNoncurrentAssets1">Other non-current assets</in-capmkt:DescriptionOfOtherNoncurrentAssets><in-capmkt:OtherNoncurrentAssets contextRef="I_OtherNoncurrentAssets1" decimals="-3" unitRef="INR">11039000</in-capmkt:OtherNoncurrentAssets><in-capmkt:AdjustmentsForFinanceCosts contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForFinanceCosts><in-capmkt:AdjustmentsForDepreciationAndAmortisationExpense contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForDepreciationAndAmortisationExpense><in-capmkt:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss><in-capmkt:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForUnrealisedForeignExchangeLossesGains><in-capmkt:AdjustmentsForDividendIncome contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForDividendIncome><in-capmkt:AdjustmentsForSharebasedPayments contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForSharebasedPayments><in-capmkt:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow><in-capmkt:OtherAdjustmentsToReconcileProfitLoss contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsToReconcileProfitLoss><in-capmkt:OtherAdjustmentsForNoncashItems contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsForNoncashItems><in-capmkt:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:AdjustmentsToProfitLoss contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsToProfitLoss><in-capmkt:AdjustmentsForDecreaseIncreaseInInventories contextRef="OneD" decimals="-3" unitRef="INR">2025000</in-capmkt:AdjustmentsForDecreaseIncreaseInInventories><in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivables contextRef="OneD" decimals="-3" unitRef="INR">26089000</in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivables><in-capmkt:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="OneD" decimals="-3" unitRef="INR">1053000</in-capmkt:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets><in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayables contextRef="OneD" decimals="-3" unitRef="INR">-363000</in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayables><in-capmkt:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="OneD" decimals="-3" unitRef="INR">-2825000</in-capmkt:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities><in-capmkt:AdjustmentsForProvisions contextRef="OneD" decimals="-3" unitRef="INR">-1301000</in-capmkt:AdjustmentsForProvisions><in-capmkt:AdjustmentsForWorkingCapital contextRef="OneD" decimals="-3" unitRef="INR">24678000</in-capmkt:AdjustmentsForWorkingCapital><in-capmkt:AdjustmentsForReconcileProfitLoss contextRef="OneD" decimals="-3" unitRef="INR">24678000</in-capmkt:AdjustmentsForReconcileProfitLoss><in-capmkt:CashFlowsFromUsedInOperations contextRef="OneD" decimals="-3" unitRef="INR">-17926000</in-capmkt:CashFlowsFromUsedInOperations><in-capmkt:DividendsReceivedClassifiedAsOperatingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsReceivedClassifiedAsOperatingActivities><in-capmkt:InterestPaidClassifiedAsOperatingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:InterestPaidClassifiedAsOperatingActivities><in-capmkt:InterestReceivedClassifiedAsOperatingActivities contextRef="OneD" decimals="-3" unitRef="INR">345000</in-capmkt:InterestReceivedClassifiedAsOperatingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxesPaidRefundClassifiedAsOperatingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="OneD" decimals="-4" unitRef="INR">-64280000</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities><in-capmkt:CashFlowsFromUsedInOperatingActivitiesBeforeExtraordinaryItems contextRef="OneD" decimals="-3" unitRef="INR">-81861000</in-capmkt:CashFlowsFromUsedInOperatingActivitiesBeforeExtraordinaryItems><in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsOperatingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsOperatingActivities><in-capmkt:PaymentForExtraordinaryItemsClassifiedAsOperatingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentForExtraordinaryItemsClassifiedAsOperatingActivities><in-capmkt:CashFlowsFromUsedInOperatingActivities contextRef="OneD" decimals="-3" unitRef="INR">-81861000</in-capmkt:CashFlowsFromUsedInOperatingActivities><in-capmkt:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities><in-capmkt:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities><in-capmkt:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities><in-capmkt:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities><in-capmkt:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities><in-capmkt:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities><in-capmkt:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="OneD" decimals="-4" unitRef="INR">3180000</in-capmkt:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities><in-capmkt:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities><in-capmkt:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities><in-capmkt:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities><in-capmkt:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities><in-capmkt:DividendsReceivedClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsReceivedClassifiedAsInvestingActivities><in-capmkt:InterestReceivedClassifiedAsInvestingActivities contextRef="OneD" decimals="-3" unitRef="INR">-345000</in-capmkt:InterestReceivedClassifiedAsInvestingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxesPaidRefundClassifiedAsInvestingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities><in-capmkt:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities><in-capmkt:CashFlowsFromUsedInInvestingActivitiesBeforeExtraordinaryItems contextRef="OneD" decimals="-3" unitRef="INR">-3525000</in-capmkt:CashFlowsFromUsedInInvestingActivitiesBeforeExtraordinaryItems><in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsInvestingActivities><in-capmkt:PaymentForExtraordinaryItemsClassifiedAsInvestingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentForExtraordinaryItemsClassifiedAsInvestingActivities><in-capmkt:CashFlowsFromUsedInInvestingActivities contextRef="OneD" decimals="-3" unitRef="INR">-3525000</in-capmkt:CashFlowsFromUsedInInvestingActivities><in-capmkt:ProceedsFromIssuingShares contextRef="OneD" decimals="-3" unitRef="INR">27143000</in-capmkt:ProceedsFromIssuingShares><in-capmkt:ProceedsFromIssuingOtherEquityInstruments contextRef="OneD" decimals="-3" unitRef="INR">27875000</in-capmkt:ProceedsFromIssuingOtherEquityInstruments><in-capmkt:ProceedsFromIssuingDebenturesNotesBondsEtc contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromIssuingDebenturesNotesBondsEtc><in-capmkt:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="OneD" decimals="-3" unitRef="INR">-23922000</in-capmkt:ProceedsFromBorrowingsClassifiedAsFinancingActivities><in-capmkt:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="OneD" decimals="-3" unitRef="INR">454000</in-capmkt:RepaymentsOfBorrowingsClassifiedAsFinancingActivities><in-capmkt:DividendsPaidClassifiedAsFinancingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsPaidClassifiedAsFinancingActivities><in-capmkt:InterestPaidClassifiedAsFinancingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:InterestPaidClassifiedAsFinancingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsFinancingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxesPaidRefundClassifiedAsFinancingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="OneD" decimals="-3" unitRef="INR">67857000</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities><in-capmkt:CashFlowsFromUsedInFinancingActivitiesBeforeExtraordinaryItems contextRef="OneD" decimals="-3" unitRef="INR">98499000</in-capmkt:CashFlowsFromUsedInFinancingActivitiesBeforeExtraordinaryItems><in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsFinancingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromExtraordinaryItemsClassifiedAsFinancingActivities><in-capmkt:PaymentForExtraordinaryItemsClassifiedAsFinancingActivities contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentForExtraordinaryItemsClassifiedAsFinancingActivities><in-capmkt:CashFlowsFromUsedInFinancingActivities contextRef="OneD" decimals="-3" unitRef="INR">98499000</in-capmkt:CashFlowsFromUsedInFinancingActivities><in-capmkt:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="OneD" decimals="-3" unitRef="INR">13113000</in-capmkt:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges><in-capmkt:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:EffectOfExchangeRateChangesOnCashAndCashEquivalents><in-capmkt:IncreaseDecreaseInCashAndCashEquivalents contextRef="OneD" decimals="-3" unitRef="INR">13113000</in-capmkt:IncreaseDecreaseInCashAndCashEquivalents><in-capmkt:CashAndCashEquivalentsCashFlowStatement contextRef="PY_I" decimals="-3" unitRef="INR">13032000</in-capmkt:CashAndCashEquivalentsCashFlowStatement><in-capmkt:CashAndCashEquivalentsCashFlowStatement contextRef="OneI" decimals="-3" unitRef="INR">26145000</in-capmkt:CashAndCashEquivalentsCashFlowStatement></xbrli:xbrl>